Evidence map›Paper›PMID 33318174›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Allosteric cooperation in a de novo-designed two-domain protein.

Fabio Pirro, Nathan Schmidt, James Lincoff, Zachary X Widel, Nicholas F Polizzi, Lijun Liu, Michael J Therien, Michael Grabe, Marco Chino, Angela Lombardi and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. An expandable, modular de novo protein platform for precision redox engineering.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Article
  14. Research square · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Catalysis and Electron Transfer inChemical reviews · 2022
    Review
  19. De novo metalloprotein design.Nature reviews. Chemistry · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Fabio PirroDepartment of Chemical Sciences, University of Napoli Federico II, 80126 Napoli, Italy.ORCID 0000-0002-6256-6486
Nathan SchmidtDepartment of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California, San Francisco, CA 94158-9001.
James LincoffDepartment of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California, San Francisco, CA 94158-9001.ORCID 0000-0003-3090-1240
Zachary X WidelDepartment of Chemistry, Duke University, Durham, NC 27708-0346.ORCID 0000-0003-3550-4498
Nicholas F PolizziDepartment of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California, San Francisco, CA 94158-9001.
Lijun LiuState Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, 518055 Shenzhen, China.ORCID 0000-0003-0514-281X
Michael J TherienDepartment of Chemistry, Duke University, Durham, NC 27708-0346.ORCID 0000-0003-4876-0036
Michael GrabeDepartment of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California, San Francisco, CA 94158-9001.ORCID 0000-0003-3509-5997
Marco ChinoDepartment of Chemical Sciences, University of Napoli Federico II, 80126 Napoli, Italy.ORCID 0000-0002-0436-3293
Angela LombardiDepartment of Chemical Sciences, University of Napoli Federico II, 80126 Napoli, Italy; alombard@unina.it william.degrado@ucsf.edu.ORCID 0000-0002-2013-3009
William F DeGradoDepartment of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California, San Francisco, CA 94158-9001; alombard@unina.it william.degrado@ucsf.edu.ORCID 0000-0003-4745-263X
University of California, San Francisco · USUniversity of Naples Federico II · ITDuke University · USPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the de novo design of an allosterically regulated protein, which comprises two tightly coupled domains. One domain is based on the DF (Due Ferri in Italian or two-iron in English) family of de novo proteins, which have a diiron cofactor that catalyzes a phenol oxidase reaction, while the second domain is based on PS1 (Porphyrin-binding Sequence), which binds a synthetic Zn-porphyrin (ZnP). The binding of ZnP to the original PS1 protein induces changes in structure and dynamics, which we expected to influence the catalytic rate of a fused DF domain when appropriately coupled. Both DF and PS1 are four-helix bundles, but they have distinct bundle architectures. To achieve tight coupling between the domains, they were connected by four helical linkers using a computational method to discover the most designable connections capable of spanning the two architectures. The resulting protein, DFP1 (Due Ferri Porphyrin), bound the two cofactors in the expected manner. The crystal structure of fully reconstituted DFP1 was also in excellent agreement with the design, and it showed the ZnP cofactor bound over 12 Å from the dimetal center. Next, a substrate-binding cleft leading to the diiron center was introduced into DFP1. The resulting protein acts as an allosterically modulated phenol oxidase. Its Michaelis-Menten parameters were strongly affected by the binding of ZnP, resulting in a fourfold tighter

Indexed as

Protein EngineeringAllosteric RegulationBiocatalysisCoenzymesLigandsMetalsModels, MolecularOxidation-ReductionProtein DomainsProtein Structure, SecondaryRecombinant ProteinsCoenzymesLigandsMetalsRecombinant Proteinsallosteryde novo designdiiron proteinporphyrin-binding proteinprotein evolution

Identifiers

PMID33318174
PMCPMC7776816
OpenAlexW3112463351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.